DWS ESG Biotech LC
- ISIN
- DE0009769976
- Provider
- DWS Investment GmbH
- Close Price
- €351.71 *
- Lipper Rating
- ESG Score
- Characteristics
- Sustainable
* Data as of 8 September 2026
Performance
Loading...
| Total | p.a. | |
|---|---|---|
| YTD | +12.27% | — |
| 1 Year | +37.51% | +37.51% |
| 3 Years | +43.19% | +12.70% |
| 5 Years | +27.63% | +5.00% |
| 10 Years | +105.64% | +7.47% |
Past performance is not a reliable indicator of future results. The value of an investment and the income from it can fall as well as rise.
Key Facts
| Asset Class | Equity |
| Holdings Classification | Equity United States Multi-Cap Growth |
| Geographical Focus | United States of America |
| Fund Size | €377,377,183 |
| Total Expense Ratio | 1.50% |
| Currency | EUR |
| Domicile | DE |
| Managementstyle | Active |
| SFDR Article | Article 8 |
Available in
Liechtenstein Life InvestLiechtenstein Life PensionLiechtenstein Life WealthProsperity PlusVWL-Förderkonzept für Bundeswehrangehörigebest value rentvalue invest VWLvalue rent business UK
Country Exposure
United States
77.7%
Netherlands
7.6%
Denmark
3.0%
United Kingdom
2.7%
Switzerland
1.7%
Other
7.3%
Description
The fund is actively managed and not managed with reference to a benchmark. The fund promotes environmental and social characteristics and is subject to the disclosure requirements of a financial product in accordance with Article 8(1) of Regulation (EU) 2019/2088 on sustainability-related disclosur...